Recent reports have showed that LPS/toll-like receptor 4 (TLR4)/NF-κB signaling is critical for the activation of inflammatory pathways associated with NASH [10]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.